Logo image of EBUS.AS

EBUSCO HOLDING NV (EBUS.AS) Stock Fundamental Analysis

AMS:EBUS - Euronext Amsterdam - NL0015002AG2 - Common Stock - Currency: EUR

0.586  +0.02 (+4.34%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to EBUS. EBUS was compared to 105 industry peers in the Machinery industry. EBUS has a bad profitability rating. Also its financial health evaluation is rather negative. EBUS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year EBUS has reported negative net income.
EBUS had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EBUS reported negative net income in multiple years.
In the past 5 years EBUS always reported negative operating cash flow.
EBUS.AS Yearly Net Income VS EBIT VS OCF VS FCFEBUS.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -50M -100M

1.2 Ratios

EBUS has a Return On Assets of -50.80%. This is amonst the worse of the industry: EBUS underperforms 91.35% of its industry peers.
EBUS has a Return On Equity of -120.90%. This is amonst the worse of the industry: EBUS underperforms 88.46% of its industry peers.
Industry RankSector Rank
ROA -50.8%
ROE -120.9%
ROIC N/A
ROA(3y)-18.36%
ROA(5y)-6.06%
ROE(3y)-28.84%
ROE(5y)-0.21%
ROIC(3y)N/A
ROIC(5y)N/A
EBUS.AS Yearly ROA, ROE, ROICEBUS.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

1.3 Margins

EBUS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EBUS.AS Yearly Profit, Operating, Gross MarginsEBUS.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

EBUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EBUS has more shares outstanding
The number of shares outstanding for EBUS has been reduced compared to 5 years ago.
EBUS has a worse debt/assets ratio than last year.
EBUS.AS Yearly Shares OutstandingEBUS.AS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
EBUS.AS Yearly Total Debt VS Total AssetsEBUS.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

EBUS has an Altman-Z score of -1.90. This is a bad value and indicates that EBUS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of EBUS (-1.90) is worse than 78.85% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that EBUS is not too dependend on debt financing.
EBUS has a Debt to Equity ratio of 0.11. This is amongst the best in the industry. EBUS outperforms 86.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -1.9
ROIC/WACCN/A
WACC5.78%
EBUS.AS Yearly LT Debt VS Equity VS FCFEBUS.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

2.3 Liquidity

EBUS has a Current Ratio of 1.30. This is a normal value and indicates that EBUS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of EBUS (1.30) is worse than 63.46% of its industry peers.
A Quick Ratio of 0.56 indicates that EBUS may have some problems paying its short term obligations.
EBUS has a Quick ratio of 0.56. This is amonst the worse of the industry: EBUS underperforms 86.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.56
EBUS.AS Yearly Current Assets VS Current LiabilitesEBUS.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for EBUS have decreased strongly by -224.81% in the last year.
EBUS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.07%.
Measured over the past years, EBUS shows a very strong growth in Revenue. The Revenue has been growing by 36.83% on average per year.
EPS 1Y (TTM)-224.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65%
Revenue 1Y (TTM)-15.07%
Revenue growth 3Y0.81%
Revenue growth 5Y36.83%
Sales Q2Q%-8.91%

3.2 Future

EBUS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.94% yearly.
The Revenue is expected to grow by 48.07% on average over the next years. This is a very strong growth
EPS Next Y-49.62%
EPS Next 2Y30.78%
EPS Next 3Y30.29%
EPS Next 5Y19.94%
Revenue Next Year-8.52%
Revenue Next 2Y10.61%
Revenue Next 3Y34.82%
Revenue Next 5Y48.07%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EBUS.AS Yearly Revenue VS EstimatesEBUS.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
EBUS.AS Yearly EPS VS EstimatesEBUS.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 -1 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

EBUS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EBUS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EBUS.AS Price Earnings VS Forward Price EarningsEBUS.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EBUS.AS Per share dataEBUS.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

EBUS's earnings are expected to grow with 30.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.78%
EPS Next 3Y30.29%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EBUS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EBUSCO HOLDING NV

AMS:EBUS (3/7/2025, 7:00:00 PM)

0.586

+0.02 (+4.34%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners18.96%
Inst Owner ChangeN/A
Ins Owners17.25%
Ins Owner ChangeN/A
Market Cap38.37M
Analysts38
Price Target1.54 (162.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-84.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)36.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-13.9%
Revenue NY rev (3m)-13.9%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.39
P/FCF N/A
P/OCF N/A
P/B 0.31
P/tB 0.53
EV/EBITDA N/A
EPS(TTM)-5.18
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)-1.54
FCFYN/A
OCF(TTM)-1.34
OCFYN/A
SpS1.51
BVpS1.87
TBVpS1.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.8%
ROE -120.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-18.36%
ROA(5y)-6.06%
ROE(3y)-28.84%
ROE(5y)-0.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 142.11%
Cap/Sales 13.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.56
Altman-Z -1.9
F-Score1
WACC5.78%
ROIC/WACCN/A
Cap/Depr(3y)143.07%
Cap/Depr(5y)111.08%
Cap/Sales(3y)14.44%
Cap/Sales(5y)9.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-224.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65%
EPS Next Y-49.62%
EPS Next 2Y30.78%
EPS Next 3Y30.29%
EPS Next 5Y19.94%
Revenue 1Y (TTM)-15.07%
Revenue growth 3Y0.81%
Revenue growth 5Y36.83%
Sales Q2Q%-8.91%
Revenue Next Year-8.52%
Revenue Next 2Y10.61%
Revenue Next 3Y34.82%
Revenue Next 5Y48.07%
EBIT growth 1Y-76.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-0.98%
EBIT Next 3Y37.96%
EBIT Next 5Y29.69%
FCF growth 1Y-17.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.84%
OCF growth 3YN/A
OCF growth 5YN/A